Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function

Brain

Volumn 128, Issue 11, 2005, Pages 2597-2611

  Honey, Garry D ^a   Pomarol Clotet, Edith ^a   Corlett, Philip R ^a   Honey, Rebekah A E ^a   Mckenna, Peter J ^a   Bullmore, Edward T ^a   Fletcher, Paul C ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Attention deficit; Cognitive function; Functional imaging; Schizophrenia

Indexed keywords

ADULT; ARTICLE; ATTENTION; BRAIN; CEREBELLUM; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HUMAN; MALE; MOTOR PERFORMANCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOM; TASK PERFORMANCE;

ADULT; AGE OF ONSET; ATTENTION; BRAIN MAPPING; CEREBELLUM; DISCRIMINATION (PSYCHOLOGY); FEMALE; GYRUS CINGULI; HUMANS; INTELLIGENCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 27644513171     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awh632     Document Type: Article

References (101)

1. Addington J, Addington D. Attentional vulnerability indicators in schizophrenia and bipolar disorder. Schizophr Res 1997; 23: 197-204.
2. Allman JM, Hakeem A, Erwin JM, Nimchinsky E, Hof P. The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann N Y Acad Sci 2001; 935: 107-17.
3. Andreasen NC, Flaum M, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 1992a; 49: 615-23.
4. Andreasen NC, Rezai K, Alliger R, Swayze IV, Flaum M, Kirchner P, et al. Hypofrontality in neuroleptic-naïve patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 1992b; 49: 943-58.
5. Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Ponto LL, et al. Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci USA 1996; 93: 9985-90.
6. Andreasen NC, Paradiso S, O'Leary DS. 'Cognitive dysmetria' as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical- cerebellar circuitry? Schizophr Bull 1998; 24: 203-18.
7. Andreasen NC, Nopoulos P, O'Leary DS, Miller DD, Wassink T, Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry 1999; 46: 908-20.
8. Bates JF, Goldman-Rakic PS. Prefrontal connections of medial motor areas in the rhesus monkey. J Comp Neurol 1993; 336: 211-28.
9. Benes FM, Bird ED. An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch Gen Psychiatry 1987; 44: 608-16.
10. Berger A, Posner MI. Pathologies of brain attentional networks. Neurosci Biobehav Rev 2000; 24: 3-5.
11. Bilder RM. Neurocognitive impairment in schizophrenia and how it affects treatment options. Can J Psychiatry 1997; 42: 255-64.
12. Braff DL. Information processing and attention dysfunctions in schizophrenia. Schizophr Bull 1993; 19: 233-59.
13. Braff DL, Light GA. Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology (Berl) 2004; 174: 75-85.
14. Braus DF, Ende G, Weber-Fahr W, Demirakca T, Henn FA. Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study. Pharmacopsychiatry 2001; 34: 251-3.
15. Braus DF, Ende G, Weber-Fahr W, Demirakca T, Tost H, Henn FA. Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia. Eur Neuropsychopharmacol 2002; 12: 145-52.
16. Buchsbaum MS, Nuechterlein KH, Haier RJ, Wu J, Sicotte N, Hazlett E, et al. Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. Br J Psychiatry 1990; 156: 216-27.
17. Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, et al. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 1992; 49: 935-42.
18. Buchanan RW, Strauss ME, Breier A, Kirkpatrick B, Carpenter WT Jr. Attentional impairments in deficit and nondeficit forms of schizophrenia. Am J Psychiatry 1997; 154: 363-70.
19. Bullmore ET, Frangou S, Murray RM. The dysplastic net hypothesis: an integration of developmental and dysconnectivity theories of schizophrenia. Schizophr Res 1997; 28: 143-56.
20. Carter CS, MacDonald AW 3rd, Ross LL, Stenger VA. Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study. Am J Psychiatry 2001; 158: 1423-8.
21. Chen YC, Galpern WR, Brownell AL, Matthews RT, Bogdanov M, Isacson O, et al. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn Reson Med 1997; 38: 389-98.
22. Christensen BK, Bilder RM. Dual cytoarchitectonic trends: an evolutionary model of frontal lobe functioning and its application to psychopathology. Can J Psychiatry 2000; 45: 247-56.
23. Cohen RM, Semple WE, Gross M, Nordahl TE, DeLisi LE, Holcomb HH, et al. Dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Life Sci 1987; 40: 2031-9.
24. Cohen RM, Semple WE, Gross M, Nordahl TE, Holcomb HH, Dowling MS, et al. The effect of neuroleptics on dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Life Sci 1988; 43: 1141-50.
25. Cohen RM, Nordahl TE, Semple WE, Andreason P, Litman RE, Pickar D. The brain metabolic patterns of dozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task. Arch Gen Psychiatry 1997; 54: 481-6.
26. Cohen R, Nordahl T, Semple W, Andreason P, Pickar D. Abnormalities in the distributed network of sustained attention predicts neuroleptic treatment response in schizophrenia. Neuropsychopharmacology 1998a; 19: 35-47.
27. Cohen RM, Nordahl TE, Semple WE, Andreason P, Pickar D. Abnormalities in the distributed network of sustained attention predict neuroleptic treatment response in schizophrenia. Neuropsychopharmacology 1998b; 19: 36-47.
28. Cornblatt BA, Lenzenweger MF, Dworkin RH, Erlenmeyer-Kimling L. Positive and negative schizophrenic symptoms, attention, and information processing. Schizophr Bull 1985; 11: 397-408.
29. Crespo-Facorro B, Paradiso S, Andreasen NC, O'Leary DS, Watkins GL, Boles Ponto LL, et al. Recalling word lists reveals 'cognitive dysmetria' in schizophrenia: a positron emission tomography study. Am J Psychiatry 1999; 156: 386-92.
30. Daniel DG, Goldberg TE, Weinberger DR, Kleinman JE, Pickar D, Lubick LJ, et al. Different side effect profiles of risperidone and clozapine in 20 patients with schizophrenia or schizoaffective disorder: a pilot study. Am J Psychiatry 1996; 153: 417-9.
31. Dehaene S, Artiges E, Naccache L, Martelli C, Viard A, Schurhoff F, et al. Conscious and subliminal conflicts in normal subjects and patients with schizophrenia: the role of the anterior cingulate. Proc Natl Acad Sci USA 2003; 100: 13722-7.
32. Eyler LT, Olsen RK, Jeste DV, Brown GG. Abnormal brain response of chronic schizophrenia patients despite normal performance during a visual vigilance task. Psychiatry Res 2004; 130: 245-57.
33. Fletcher P, McKenna PJ, Friston KJ, Frith CD, Dolan RJ. Abnormal cingulate modulation of fronto-temporal connectivity in schizophrenia. Neuroimage 1999; 9: 337-42.
34. Friston KJ, Frith CD. Schizophrenia: a disconnection syndrome? Clin Neurosci 1995; 3: 89-97.
35. Friston KJ, Buechel C, Fink GR, Morris J, Rolls E, Dolan RJ. Psychophysiological and modulatory interactions in neuroimaging. Neuroimage 1997; 6: 218-29.
36. Goldberg G. Supplementary motor area: review and hypotheses. Behav Brain Sci 1985; 8: 567-88.
37. Goldberg TE, Greenberg RD, Griffin SJ, Gold JM, Kleinman JE, Pickar D, et al. The effects of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 1993; 162: 43-8.
38. Goldstein JM, Goodman JM, Seidman LJ, Kennedy DN, Makris N, Lee H, et al. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry 1999; 56: 537-47.
39. Green DM, Swets JA. Signal detection theory and psychophysics. New York: Wiley; 1966.
40. Grove WM, Lebow BS, Clementz BA, Cerri A, Medus C, Iacono WG. Familial prevalence and coaggregation of schizotypy indicators: a multitrait family study. J Abnorm Psychol 1991; 100: 115-21.
41. Hager F, Volz HP, Gaser C, Mentzel HJ, Kaiser WA, Sauer H. Challenging the anterior attentional system with a continuous performance task: a functional magnetic resonance imaging approach. Eur Arch Psychiatry Clin Neurosci 1998; 248: 161-70.
42. Hain C, Maier W, Klingler T, Franke P. Positive/negative symptomatology and experimental measures of attention in schizophrenic patients. Psychopathology 1993; 26: 62-8.
43. Heckers S, Weiss AP, Deckersbach T, Goff DC, Morecraft RJ, Bush G. Anterior cingulate cortex activation during cognitive interference in schizophrenia. Am J Psychiatry 2004; 161: 707-15.
44. Hempel A, Hempel E, Schonknecht P, Stippich C, Schroder J. Impairment in basal limbic function in schizophrenia during affect recognition. Psychiatry Res 2003; 122: 115-24.
45. Hill KE, Mann L, Laws KR, Nimmo-Smith I, McKenna PJ. Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatr Scand 2004; 110: 243-56.
46. Hofer A, Weiss EM, Golaszewski SM, Siedentopf CM, Brinkhoff C, Kremser C, et al. An FMRI study of episodic encoding and recognition of words in patients with schizophrenia in remission. Am J Psychiatry 2003; 160: 911-8.
47. Job D, Whalley H, McConnell S, Glabus M, Johnstone E, Lawrie S. Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry. Neuroimage 2002; 17: 880.
48. Johnstone EC, Frith CD. Validation of three dimensions of schizophrenic symptoms in a large unselected sample of patients. Psychol Med 1996; 26: 669-79.
49. Keefe RS, Silva SG, Perkins DO, Lieberman JA. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull 1999; 25: 201-22.
50. Keilp JG, Herrera J, Stritzke P, Cornblatt BA. The continuous performance test, identical pairs version (CPT-IP): III. Brain functioning during performance of numbers and shapes subtasks. Psychiatry Res 1997; 74: 35-45.
51. King DJ. The effects of neuroleptics on cognitive and psychomotor function. Br J Psychiatry 1990; 157: 799-811.
52. Laurens KR, Ngan ET, Bates AT, Kiehl KA, Liddle PF. Rostral anterior cingulate cortex dysfunction during error processing in schizophrenia. Brain 2003; 126: 610-22.
53. Liu SK, Hwu HG, Chen WJ. Clinical symptom dimensions and deficits on the continuous performance test in schizophrenia. Schizophr Res 1997; 25: 211-9.
54. Liu SK, Chen WJ, Chang CJ, Lin HN. Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: a trial of risperidone versus haloperidol. Neuropsychopharmacology 2000; 22: 311-9.
55. Luppino G, Matelli M, Camarda R, Rizzolati G. Cortico-cortical connections of area F3 (SMA-Proper) and area F (Pre-SMA) in the macaque monkey. J Comp Neurol 1993; 338: 114-40.
56. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003; 19: 1233-9.
57. Mass R, Wolf K, Wagner M, Haasen C. Differential sustained attention/vigilance changes over time in schizophrenics and controls during a degraded stimulus continuous performance test. Eur Arch Psychiatry Clin Neurosci 2000; 250: 24-30.
58. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A. Progressive brain vol-ume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 2001; 58:148-57.
59. Mirsky AF, Yardley SL, Jones BP, Walsh D, Kendler KS. Analysis of the attention deficit in schizophrenia: a study of patients and their relatives in Ireland. J Psychiatr Res 1995; 29: 23-42.
60. Mortimer AM. Cognitive function in schizophrenia: do neuroleptics make a difference? Pharmacol Biochem Behav 1997; 56: 789-95.
61. Nelson H. National adult reading test. New York: NFER-Nelson Publishing Company Ltd.; 1982.
62. Nuechterlein KH, Parasuraman R, Jiang Q. Visual sustained attention: image degradation produces rapid sensitivity decrement over time. Science 1983; 220: 327-9.
63. Nuechterlein KH, Edell WS, Norris M, Dawson ME. Attentional vulnerability indicators, thought disorder, and negative symptoms. Schizophr Bull 1986; 12: 408-26.
64. Nuechterlein KH. Vigilance in schizophrenia and related disorders: neuropsychology, psychophysiology and information processing. In: Steinhauer SR, Gruzelier JH and Zubin J, editors. Handbook of schizophrenia. Vol 5. Amsterdam: Elsevier; 1991. 397-433.
65. Ochsner KN, Kosslyn SM, Cosgrove GR, Cassem EH, Price BH, Nierenberg AA, et al. Deficits in visual cognition and attention following bilateral anterior cingulotomy. Neuropsychologia 2001; 39: 219-30.
66. Pandya DN, Van Hoesen GW, Mesulam MM. Efferent connections of the cingulate gyrus in the rhesus monkey. Exp Brain Res 1981; 42: 319-30.
67. Posner MI, Raichle M. Images of mind. Washington, DC: Scientific American Books; 1996.
68. Potkin SG, Alva G, Fleming K, Anand R, Keator D, Carreon D, et al. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Am J Psychiatry 2002; 159: 227-37.
69. Pugh KR, Offywitz BA, Shaywitz SE, Fulbright RK, Byrd D, Skudlarski P, et al. Auditory selective attention: an fMRI investigation. Neuroimage 1996; 4: 159-73.
70. Quintana J, Wong T, Ortiz-Portillo E, Marder SR, Mazziotta JC. Anterior cingulate dysfunction during choice anticipation in schizophrenia. Psychiatry Res 2004; 132: 117-30.
71. Ragland JD, Gur RC, Raz J, Schroeder L, Kohler CG, Smith RJ, et al. Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study. Am J Psychiatry 2001; 158: 1114-25.
72. Roitman SE, Keefe RS, Harvey PD, Siever LJ, Mohs RC. Attentional and eye tracking deficits correlate with negative symptoms in schizophrenia. Schizophr Res 1997; 26: 139-46.
73. Roswold HE, Mirsky A, Sarason I, Bransome ED, Beck LH. A continuous performance test of brain damage. J Consult Psychol 1956; 20: 343-50.
74. Rubia K. The dynamic approach to neurodevelopmental psychiatric disorders: use of fMRI combined with neuropsychology to elucidate the dynamics of psychiatric disorders, exemplified in ADHD and schizophrenia. Behav Brain Res 2002; 130: 47-56.
75. Rushworth MF, Walton ME, Kennerley SW, Bannerman DM. Action sets and decisions in the medial frontal cortex. Trends Cogn Sci 2004; 8: 410-7.
76. Salgado-Pineda P, Junque C, Vendrell P, Baeza I, Bargallo N, Falcon C, et al. Decreased cerebral activation during CPT performance: structural and functional deficits in schizophrenic patients. Neuroimage 2004; 21: 840-7.
77. Sanfilipo M, Lafargue T, Rusinek H, Arena L, Loneragan C, Lautin A, et al. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch Gen Psychiatry 2000; 57:471-80.
78. Sanides F. Comparative architectonics of the neocortex of mammals and their evolutionary interpretation. Ann N Y Acad Sci 1969; 167: 404-23.
79. Schroeder J, Buchsbaum MS, Siegel BV, Geider FJ, Haier RJ, Lohr J, et al. Patterns of cortical activity in schizophrenia. Psychol Med 1994; 24: 947-55.
80. Schroder J, Buchsbaum MS, Siegel BV, Geider FJ, Lohr J, Tang C, et al. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr Res 1996; 19: 41-53.
81. Shapleske J, Rossell SL, Chitnis XA, Suckling J, Simmons A, Bullmore ET, et al. A computational morphometric MRI study of schizophrenia: effects of hallucinations. Cereb Cortex 2002; 12: 1331-41.
82. Siegel BV Jr, Buchsbaum MS, Bunney WE Jr, Gottschalk LA, Haier RJ, Lohr JB, et al. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry 1993; 150: 1325-36.
83. Siegel BV Jr, Nuechterlein KH, Abel L, Wu JC, Buchsbaum MS. Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls. Schizophr Res 1995; 17: 85-94.
84. Sigmundsson T, Suckling J, Maier M, Williams S, Bullmore E, Greenwood K, et al. Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am J Psychiatry 2001; 158: 234-43.
85. Stark AK, Uylings HB, Sanz-Arigita E, Pakkenberg B. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am J Psychiatry 2004; 161: 882-8.
86. Stephan KE, Magnotta VA, White T, Arndt S, Flaum M, O'Leary DS, et al. Effects of olanzapine on cerebellar functional connectivity in schizophrenia measured by fMRI during a simple motor task. Psychol Med 2001; 31: 1065-78.
87. Stip E, Lussier I. The effect of risperidone on cognition in patients with schizophrenia. Can J Psychiatry 1996; 41 Suppl 2: S35-40.
88. Stuve TA, Friedman L, Jesberger JA, Gilmore GC, Strauss ME, Meltzer HY. The relationship between smooth pursuit performance, motor perception and sustained visual attention in patients with schizophrenia and normal controls. Psychol Med 1997; 27: 143-52.
89. Szeszko PR, Gunning-Dixon F, Goldman RS, Bates J, Ashtari M, Snyder PJ, et al. Lack of normal association between cerebellar volume and neuropsychological functions in first-episode schizophrenia. Am J Psychiatry 2003; 160: 1884-7.
90. Tamminga CA, Vogel M, Gao X, Lahti AC, Holcomb HH. The limbic cortex in schizophrenia: focus on the anterior cingulate. Brain Res Brain Res Rev 2000; 31: 364-70.
91. Tamminga CA, Lahti AC, Medoff DR, Gao XM, Holcomb HH. Evaluating glutamatergic transmission in schizophrenia. Ann N Y Acad Sci 2003; 1003: 113-8.
92. Thermenos HW, Seidman LJ, Breiter H, Goldstein JM, Goodman JM, Poldrack R, et al. Functional magnetic resonance imaging during auditory verbal working memory in nonpsychotic relatives of persons with schizophrenia: a pilot study. Biol Psychiatry 2004; 55: 490-500.
93. Todtenkopf MS, Vincent SL, Benes FM. A cross-study meta-analysis and three-dimensional comparison of cell counting in the anterior cingulate cortex of schizophrenic and bipolar brain. Schizophr Res 2005; 73: 79-89.
94. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15: 273-89.
95. Velakoulis D, Wood SJ, Smith DJ, Soulsby B, Brewer W, Leeton L, et al. Increased duration of illness is associated with reduced volume in right medial temporal/anterior cingulate grey matter in patients with chronic schizophrenia. Schizophr Res 2002; 57: 43-9.
96. Volz H, Gaser C, Hager F, Rzanny R, Ponisch J, Mentzel H, et al. Decreased frontal activation in schizophrenics during stimulation with the continuous performance test - a functional magnetic resonance imaging study. Eur Psychiatry 1999; 14: 17-24.
97. Weiss EM, Golaszewski S, Mottaghy FM, Hofer A, Hausmann A, Kemmler G, et al. Brain activation patterns during a selective attention test - a functional MRI study in healthy volunteers and patients with schizophrenia. Psychiatry Res 2003; 123: 1-15.
98. Wiser AK, Andreasen NC, O'Leary DS, Watkins GL, Boles Ponto LL, Hichwa RD. Dysfunctional cortico-cerebellar circuits cause 'cognitive dysmetria' in schizophrenia. Neuroreport 1998; 9: 1895-9.
99. Woo TU, Walsh JP, Benes FM. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2004; 61: 649-57.
100. Yucel M, Volker C, Collie A, Maruff P, Danckert J, Velakoulis D, et al. Impairments of response conflict monitoring and resolution in schizophrenia. Psychol Med 2002; 32: 1251-60.
101. Zahn TP, Pickar D, Haier RJ. Effects of clozapine, fluphenazine and placebo on reaction time measures of attention and sensory dominance in schizophrenia. Schizophr Res 1994; 13: 133-44.